Dr. Bruce Faddegon's lab at UCSF focuses on improving cancer treatment techniques using particle therapy, which includes protons and carbon ions. They aim to develop more precise treatment planning methods based on a detailed understanding of ionization patterns produced by these therapies. By integrating new prediction models, the lab hopes to enhance the effectiveness of radiation therapy while minimizing damage to healthy tissue, ultimately improving outcomes for cancer patients.

Dr. Xudong Fan's lab focuses on developing innovative diagnostic devices that analyze biological markers from breath and skin odors to detect and monitor various diseases. By utilizing micro-gas chromatography and machine learning, the lab aims to create portable devices for point-of-care use, enhancing diagnosis and patient monitoring for conditions like acute respiratory distress syndrome and skin diseases. Their work combines biomedical engineering, data science, and clinical expertise to significantly improve healthcare outcomes.

Dr. Yi Fan's lab at the University of Pennsylvania focuses on understanding glioblastoma, a highly aggressive brain tumor, and how it resists treatments. The research aims to explore the role of specialized cells in the tumor's blood supply and their influence on the immune response, potentially paving the way for innovative therapies that could improve patient outcomes.

Dr. Yong Fan's lab at the University of Pennsylvania focuses on using advanced artificial intelligence and machine learning techniques to study how the brain develops and functions. The research aims to improve our understanding of brain development variability in youth through the analysis of large-scale brain imaging data. By creating interpretable models and tools, the lab seeks to provide insights into individual differences in cognition and psychopathology, ultimately guiding personalized treatment approaches for brain disorders.

Dr. Sina Farsiu's lab focuses on understanding glaucoma, a major cause of blindness, by investigating how the eye's drainage system functions. They aim to develop advanced imaging technologies to observe and analyze changes in the anatomy of this system over time and in response to different treatments. The ultimate goal is to improve early diagnosis and personalize therapies for patients with glaucoma.

Dr. Zahi A. Fayad's research lab focuses on improving outcomes in organ transplantation and understanding the effects of stress on cardiovascular disease. The lab investigates how innate immune responses, called trained immunity, can influence organ rejection and explores advanced imaging techniques for assessing heart conditions like cardiac sarcoidosis. Their goal is to create better therapies for transplant recipients and improve diagnostic methods for heart disease.

Dr. Zhaohui Feng's lab at Rutgers focuses on understanding colorectal cancer, particularly the role of a protein called Parkin in cancer progression. Parkin is often downregulated in colorectal cancer, and the lab aims to explore how this affects cancer development and how it can be targeted for therapy. Their research combines advanced screening methods and mouse models to uncover new treatment strategies for colorectal cancer, especially in cases where Parkin is deficient.

Dr. Christopher Flask's lab focuses on improving cancer diagnosis and treatment monitoring using advanced MRI techniques. By developing innovative methods such as Magnetic Resonance Fingerprinting (MRF), they aim to better measure tumor blood flow and acidity. Their research highlights the potential for these techniques to be translated into clinical settings for more effective cancer therapies.

Dr. Robert Flavell's lab focuses on developing innovative therapies for cancers, specifically targeting CD46 in multiple myeloma and prostate cancer. The research aims to optimize radioimmunotherapy methods that minimize side effects while effectively treating tumors. The lab combines various scientific disciplines, including chemistry, biology, and imaging, to advance cancer treatment strategies and enhance diagnostic methods.

Dr. Candace C. Fleischer's lab at Emory University focuses on measuring and understanding brain temperature, particularly after injuries such as strokes. The research aims to develop new, non-invasive techniques using magnetic resonance imaging to monitor brain temperature, which is crucial for patient recovery. By combining these techniques with advanced simulations, the lab seeks to improve treatment and prognostic evaluations for patients with cerebrovascular diseases.

Dr. Kurt E. Beschorner's lab at the University of Pittsburgh focuses on improving safety in the food service industry, particularly by preventing slip and fall accidents through better footwear technology. The lab develops tools to help workers choose the right shoes and determine when to replace them, based on new research about shoe-floor interactions. By gathering data on how different shoes perform in various working conditions, the lab aims to enhance safety practices and ultimately reduce injuries for food service workers.

Dr. Karen L. Troy's lab at Worcester Polytechnic Institute focuses on understanding how the biomechanics of the foot, particularly during running, relate to injuries like bone stress injuries in athletes. The lab investigates the effects of different types of footwear—minimal versus cushioned—on foot structure and strength. By studying runners who are accustomed to these different shoe types, Dr. Troy aims to uncover how habitual footwear can affect muscle and bone adaptation, which is critical for injury prevention strategies.

David Fuentes' lab specializes in developing sophisticated mathematical models to understand and optimize a new therapeutic approach for treating liver cancer. The team focuses on how fluids behave and transfer heat within biological tissues, especially during a treatment called thermoembolization. Their interdisciplinary approach combines knowledge from areas like imaging, biochemistry, and interventional radiology to enhance cancer treatment protocols.

Dr. Lars R. Furenlid's lab focuses on innovative imaging technologies to improve brain imaging for medical research and diagnostics. They are developing a new hybrid imaging system that combines gamma-ray and positron emission imaging to visualize brain structures at high resolution. This technology could enhance our understanding of brain function and disorders by allowing detailed imaging of how radiotracers interact in the brain.

Dr. Moustafa Gabr's lab at Weill Medical College focuses on developing small molecule therapies to tackle challenging diseases like Alzheimer's, inflammatory bowel disease (IBD), and glioblastoma. They utilize an innovative platform to identify molecules that can modulate the immune response, aiming to enhance treatment efficacy and minimize side effects compared to traditional biologics. The lab emphasizes harnessing the power of small molecules to interact with key immune receptors to improve therapeutic outcomes.

Dr. Brian D. Schmit's lab focuses on improving mobility and balance for individuals with multiple sclerosis through innovative gait training. They explore the effects of high-intensity exercises combined with dynamic balance challenges to enhance walking function and overall quality of life for patients. The research aims to develop effective rehabilitation strategies that address the specific locomotor and postural control needs of individuals with neurological disorders.

Dr. Yongsheng Gao's lab at the University of Texas Dallas is focused on developing innovative synthetic materials to help manage traumatic bleeding in emergency situations. By creating microgel-based synthetic platelets that mimic the properties of natural platelets, the lab aims to improve the way we stop bleeding at injury sites. This research has significant implications for trauma care, potentially saving lives in critical situations.

Dr. James C. Gee's lab at the University of Pennsylvania focuses on enhancing imaging technologies in biomedical research. Their main project, the Advanced Normalization Tools (ANTs), is an open-source software library that offers powerful tools for image processing and analysis, benefiting researchers across various fields. The lab aims to modernize and expand this toolkit to support complex imaging needs and meet the growing demands of the scientific community.

Dr. Ann G. Schwartz's lab at Wayne State University focuses on understanding the genetic factors influencing cancer risk and outcomes, particularly in the African American community. The lab conducts extensive research on cancer survivors, aiming to identify genetic predispositions and barriers to genetic counseling. Their work seeks to improve cancer prevention and treatment strategies through community engagement and personalized medicine.

Dr. Priyanka Gopal's research lab at Northwestern University focuses on understanding how genetic features influence the effectiveness of radiotherapy in lung cancer treatment. The lab works on characterizing treatment resistance and aims to develop personalized therapies based on genetic markers. They conduct extensive genomic studies and utilize preclinical models to improve patient outcomes in cancer care, especially for those undergoing radiotherapy.